0
Skip to Content
Vital Biomedical
News
The Culture Desk RX
The Daily D.
Medical Joke of the Day
Donate
Contact
About
Login Account
Vital Biomedical
News
The Culture Desk RX
The Daily D.
Medical Joke of the Day
Donate
Contact
About
Login Account
Folder: HOME
Back
News
The Culture Desk RX
The Daily D.
Medical Joke of the Day
Donate
Contact
About
Login Account
Drugs & Devices, Research Emma Nguyễn 11/19/26 Drugs & Devices, Research Emma Nguyễn 11/19/26

Helus Psychedelic HLP003 Hits Phase 3 Depression Goal, but Serious Adverse Events Draw Scrutiny

Helus Pharma says its deuterated psilocin beat placebo on depression scores at six and 12 weeks in a 222-patient Phase 3 trial. Three treatment-related serious adverse events, including a suicide attempt, have prompted safety questions. The data have not been peer-reviewed.

Read More
Newsletter Block
This newsletter signup form needs a storage option. Edit the block and enter a storage location via the Storage tab.

Subscribe

Sign up with your email address to receive news and updates.

We respect your privacy.

Thank you!

© 2026 Vital Biomedical News. Content is for informational purposes only and is not medical advice. About · Contact